undamentalytics Newsletter
Sign in

Arcturus Therapeutics Holdings Inc. balance sheet

At the end of fiscal 2025, Arcturus Therapeutics Holdings Inc. had total assets of $271m, total liabilities of $57.2m and shareholders' equity of $214m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents3771463370392292237231191
Receivables4223332462
Total current assets4274468379403387306241197
Total assets4482476393450429344271224
Accounts payable26111075744
Deferred revenue (current)68184329452086
Total current liabilities13215010012782653634
Short-term debt——12261————
Long-term debt10151441—————
Total debt1015156393200—0
Total liabilities3156801651801511035753
Shareholders' equity1426397228270279241214172
Net debt (negative = net cash)−27−56−448−307−299−272−237−231−191
Shares outstanding11m——26m27m27m27m28m28m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ARCT vs TNXPARCT vs GLUEARCT vs STOK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Arcturus Therapeutics Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Arcturus Therapeutics Holdings Inc.